Latest Public Health News

Recce Pharmaceuticals has successfully dosed all patients in its Phase II trial of RECCE® 327 topical gel for acute bacterial skin infections, showing encouraging preliminary efficacy and safety data. The company is preparing for pivotal Phase III trials in Australia and Indonesia, targeting a significant global market opportunity.

Unith Ltd has strengthened its financial position through a partial divestment in AudioStack while renewing a key public health contract and achieving its highest B2C subscription revenue in two years.